Target-selective MG53-containing extracellular vesicles delivery in acute and chronic kidney injury
Abstract Acute kidney injury (AKI) is a sudden loss of kidney function associated with high morbidity and mortality, and effective therapy remains an unmet need. We previously showed that MG53, a muscle-predominant protein, confers kidney protection against ischemia–reperfusion (I/R) injury and unilateral ureteral obstruction (UUO)-mediated kidney fibrosis. Here, we show that limb remote ischemic preconditioning (RIPC) partially attenuates tubular apoptosis alongside a trend toward functional renal improvement against I/R-AKI, an event accompanied by a systemic surge of circulating MG53-containing extracellular vesicles (EVs). While the exact systemic trafficking kinetics and precise tissue origins of this native endogenous pool remain a proposed working hypothesis, a stark, exclusive 2.3-fold upregulation of MG53 cargo occurs exclusively within the injured renal microenvironment. To evaluate the translational utility of this axis, we characterized exogenous MG53-containing EVs derived from C2C12 myotubes (EV C2C12 ) or engineered NIH3T3 cells (EV MMT ). Upon intravenous administration, these vehicles exhibited rapid, injury-dependent accumulation within damaged proximal tubules. Utilizing a chronic injection regimen, sustained delivery of these payloads successfully mitigated baseline renal functional defects (Scr and UPCR) in mg53 -/- mice. Finally, in vitro assays demonstrate that MG53-containing EVs uptake is closely associated with intracellular AKT activation and enhances proximal tubule cell metabolic activity during hypoxia/reoxygenation stress. In summary, this work underscores the reparative capacity of endogenous MG53 accumulation while establishing that exogenous vesicular delivery serves as a viable translational strategy within an integrated muscle-kidney crosstalk axis.
Authors
- Pu Duann (ORCID: https://orcid.org/0000-0002-0145-3058)
- Pei‐Hui Lin (ORCID: https://orcid.org/0000-0002-3894-5099)
- Haichang Li (ORCID: https://orcid.org/0000-0001-9784-6480)
- Brad H. Rovin (ORCID: https://orcid.org/0000-0001-5639-0210)
- Min Zhang (ORCID: https://orcid.org/0000-0002-5443-0992)
Institutions
- The Ohio State University Wexner Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1038/s41598-026-78112-1
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00